ASH1L and rheumatoid arthritis: Furthermore, ASH1L, SMAD3 and FOXP3 are all downregulated in CD4+ T cells from PBMCs of patients with rheumatoid arthritis, indicating the potential significance of ASH1L/SMAD3/FOXP3 pathway in human autoimmune pathogenesis.